Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  isoniazid
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-14 of 14 for your search:
Start Over
Phase III Adjuvant Immunotherapy and Radiotherapy for Resectable Squamous, Adeno or Large Cell Lung Carcinoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7718
Surgery and Adjuvant Immunotherapy with BCG and Levamisole for Completely Resected non-Small Cell Cancer of the Lung
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WA-LUN-1, NOG-2177
Phase III Adjuvant BCG/INH/LEV Immunotherapy vs CAP-I (CTX/ADR/CACP) for Stage II/III Large Cell and Adenocarcinoma of the Lung
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: LCSG-772
Phase III Immunotherapy with BCG for Stage I/II/III Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MI-LUN-1
Phase III Immunotherapy with BCG for Stage I Resected non-Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NY-LUN-1, NCI-C76-164
Phase III Intradermal BCG plus Nontumorigenic Autologous Cancer Cells for Resected Stage II/III Lung and Esophageal Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-C83-0695, C83-0695
Phase II Pilot Immunotherapy with Intraperitoneal BCG plus Melphalan/Isoniazid Chemotherapy for Stage IC, II or III Ovarian Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-PE-878
Prospective LEV/Radiation vs LEV/BCG/Radiation vs Radiation Alone for Advanced non-Small Cell Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-006-225, YALE-1683
Immunotherapy with BCG/LEV plus INH vs LEV Alone as Adjuvant to Surgery for non-Oat Cell Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: NCI-D78-018-075, DFCI-77063
Resection plus BCG plus Chemotherapy with CACP/IPP vs Resection plus BCG Alone for non-Oat Cell Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D78-035-253, OSU-100-7814
Intrapleural vs Intradermal BCG for non-Small Cell Carcinoma of the Lung without Lymphnode Metastases
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: VASOG-34A
Immunotherapy with Intratumoral BCG Prior to Surgery for non-Small Cell Carcinoma of the Lung
Phase: No phase specified
Type: Treatment
Status: Closed
Age: under 80
Sponsor:
Protocol IDs: YALE-LUN-1
Start Over